Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
about
Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriersUptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriersSatisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.Gynecologic cancers associated with Lynch syndrome/HNPCC.Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.Hereditary ovarian and breast cancer: what have we learned?Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy
P2860
Q33328135-FA9FB126-D7C9-41CA-BBF6-D6EB5C2FCCACQ34125241-54F849ED-1E2E-4BE6-B55D-BD6F5BE6817BQ34309892-A31D85A9-7DE5-47FB-AC8E-4A24279BAD41Q34351382-92985210-F361-4F50-A6F8-4F60C9986CF8Q34626842-43FB5862-A9DD-44BB-B4F0-3B0D716F4D45Q35021170-B1C49328-AE7D-45BB-947A-6114F9CE0801Q35768137-30BC8499-C0DC-4498-8FD7-EC6F687132B2Q36884728-60BD2130-BE11-4DA1-89FD-64B8E7AA46DCQ37192947-2BD9AB5D-305B-4638-83C7-52B52EBB075AQ37608096-C4C6FB3E-9B12-4FB1-BABB-FE08592B0F57Q38153188-8F02E2AE-0BE7-43CB-A26E-CBC5C6E7A9D6Q38599703-79537794-9963-4F83-A182-4C474CBA78B7Q44696764-8591DDC9-65DF-410A-9592-D9204477FF60Q46755164-A4813FDF-94A9-4F3C-8AEB-CD6F493543C4Q46971163-8527A031-B818-4E4F-B3D6-42379EB2A8F5Q50137319-19E086B1-15F5-4119-AF87-8BB9EF253555Q58580413-78E0F78E-D035-4E46-A32F-8B8DB80F1BC9
P2860
Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prophylactic bilateral salping ...... in women with BRCA mutations.
@en
Prophylactic bilateral salping ...... in women with BRCA mutations.
@nl
type
label
Prophylactic bilateral salping ...... in women with BRCA mutations.
@en
Prophylactic bilateral salping ...... in women with BRCA mutations.
@nl
prefLabel
Prophylactic bilateral salping ...... in women with BRCA mutations.
@en
Prophylactic bilateral salping ...... in women with BRCA mutations.
@nl
P2093
P1476
Prophylactic bilateral salping ...... e in women with BRCA mutations
@en
P2093
Anne R Uyei
Banu K Arun
Brian M Slomovitz
Charlotte C Sun
David M Gershenson
Julie L Erlichman
Karen H Lu
Kathleen M Schmeler
Kristin G White
Michael R Milam
P304
P356
10.1097/01.AOG.0000228959.30577.13
P407
P433
P577
2006-09-01T00:00:00Z